BlinkLab Halts Trading Ahead Of Shank2 Autism Study Results
BB1: $0.570 +0.00% · MC: $106M
BlinkLab Limited requested a trading halt pending the release of results from its Shank2 autism study. Trading is expected to resume when the results announcement is released or at the start of normal trading on Wednesday, whichever comes first.

Comments